Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by University of Miami
Sponsor:
Collaborator:
Oswaldo Cruz Foundation
Information provided by (Responsible Party):
Catherine Boulanger, University of Miami
ClinicalTrials.gov Identifier:
NCT01700790
First received: October 2, 2012
Last updated: December 6, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)